WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 26, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 06/26/2025
|
July 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against WST
- NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST).
- 06/26/2025
|
WST DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class Action – WST
- NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
- 06/26/2025
|
WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus
- West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
- 06/26/2025
|
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK - June 26, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025. Follow the link below to get more information and be contacted by a member of our team: aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=154148&wire=56WST investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin HVP portfolio; (b) Wests SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Companys profit margins due to operational inefficiencies; (c) these margin pressures created the risk of costly restructuring activities, including the Companys exit from continuous glucose monitoring contracts with longstanding customers; and (d) as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in West Pharmaceutical Services, Inc. during the relevant time frame, you have until July 7, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To learn more about this case, subscribe to the Bulls & Betrayals podcast, which features a dedicated episode unpacking the allegations against West Pharmaceutical Services, Inc.. Listen now and find out if you are eligible to join the lawsuit. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT: Levi & Korsinsky, LLPJoseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 17th Floor New York, NY 10004 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.comCopyright 2025 JCN Newswire . All rights reserved.© Japan Corporate News, source JCN Press Releases
- 06/26/2025
|
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- NEW YORK , June 26, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 06/26/2025
|
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
- The magic of dividends is that you don't need to do anything to earn them aside from holding the stocks that pay them. Someone who accumulates enough dividend stocks could live off their portfolio's passive income stream and never have to work another day in their life.
- 06/26/2025
|
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , June 25, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/25/2025
|
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , June 25, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). IF YOU SUFFERED A LOSS ON YOUR WEST INVESTMENTS, CLICK HERE BEFORE JULY 7, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 06/25/2025
|
Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
- NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
- 06/24/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST) and certain of its officers.
- 06/24/2025
|
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- LOS ANGELES, June 24, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”).
- 06/24/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 06/24/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders
- NEW YORK , June 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 06/24/2025
|
WST IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important July 7 Deadline in Securities Class Action – WST
- NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
- 06/23/2025
|
Lost Money on West Pharmaceutical Services, Inc.(WST)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm
- NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 06/23/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
- 06/23/2025
|
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST
- NEW YORK , June 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 06/23/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK , June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 06/22/2025
|
WST Deadline: WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/20/2025
|
West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , June 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) have opportunity to lead the securities fraud class action lawsuit.
- 06/20/2025
|
WST DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
- NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
- 06/20/2025
|
Faruqi & Faruqi Reminds West Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 20, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 06/20/2025
|
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST
- NEW YORK , June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 06/20/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
- NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
- 06/19/2025
|
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- NEW YORK , June 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 06/19/2025
|
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit – WST
- NEW YORK, June 19, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST).
- 06/19/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
- 06/18/2025
|
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options
- 06/18/2025
|
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- BENSALEM, Pa. , June 17, 2025 /PRNewswire/ -- The Law Offices of Howard G.
- 06/17/2025
|
Securities Fraud Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Reminds Investors of July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 17, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153422&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.
- 06/17/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 06/17/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of West Pharmaceutical Services, Inc.(WST) Shareholders
- NEW YORK , June 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 06/17/2025
|
Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153398&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.
- 06/16/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153373&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.
- 06/16/2025
|
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
- 06/16/2025
|
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153324&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.
- 06/16/2025
|
WST FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/16/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 06/16/2025
|
Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
- LOS ANGELES, June 16, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”).
- 06/16/2025
|
Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153285&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.
- 06/16/2025
|
West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153232&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.
- 06/16/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / June 16, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 06/16/2025
|
The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- NEW YORK , June 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 06/16/2025
|
Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153204&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.
- 06/15/2025
|
WST Deadline: WST Investors with Losses in Excess of $100K Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , June 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/15/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
- NEW YORK, NY / ACCESS Newswire / June 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153104&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.
- 06/14/2025
|
WST FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / June 14, 2025 / WHY: New York, N.Y., June 14, 2025.
- 06/14/2025
|
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors – Lead Plaintiff Deadline July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153083&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
ROSEN, A LEADING NATIONAL FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / WHY: New York, N.Y., June 13, 2025.
- 06/13/2025
|
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153047&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST
- NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
- 06/13/2025
|
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) – Levi & Korsinsky Represents Shareholders
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153031&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=153017&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 06/13/2025
|
West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152918&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 06/13/2025
|
Investors in West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
- NEW YORK , June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 06/13/2025
|
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152892&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.
- 06/12/2025
|
WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
- NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE:WST) securities during the period from February 16, 2023, through February 12, 2025 (“the Class Period”).
- 06/12/2025
|
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152888&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.
- 06/12/2025
|
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options
- 06/12/2025
|
WST Lead Plaintiff Deadline Approaching – WST Stockholders Should Contact Robbins LLP for Information About Leading the West Pharmaceutical Services, Inc. Class Action Lawsuit
- SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025. West is a medical supplies company that specializes in the development, manufacture, and distribution of elastomer-based supplies for the containment and administration of injectable drugs.
- 06/12/2025
|
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152874&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.
- 06/12/2025
|
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152854&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.
- 06/12/2025
|
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit – WST
- NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 06/12/2025
|
July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 8, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152121&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.
- 06/08/2025
|
ROSEN, A LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / WHY: New York, N.Y., June 8, 2025.
- 06/08/2025
|
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 8, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152103&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.
- 06/08/2025
|
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 8, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152080&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.
- 06/08/2025
|
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
- NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/08/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 06/08/2025
|
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 7, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152062&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.
- 06/07/2025
|
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK, NY / ACCESS Newswire / June 7, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/07/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK , June 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 06/07/2025
|
Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152043&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.
- 06/06/2025
|
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/06/2025
|
West Pharmaceutical Services, Inc. (WST) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152034&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.
- 06/06/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151981&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.
- 06/06/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
- 06/06/2025
|
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 6, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 06/06/2025
|
Investor Alert: Deadline Approaching to Join West Pharmaceutical Services, Inc. (WST) Class Action - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151886&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.
- 06/06/2025
|
WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 06/06/2025
|
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK , June 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 06/06/2025
|
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Investors - Lead Plaintiff Deadline on July 7, 2025
- NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151851&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.
- 06/05/2025
|
WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
- NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the July 7, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE:WST) securities during the period from February 16, 2023, through February 12, 2025 (“the Class Period”).
- 06/05/2025
|
WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151836&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.
- 06/05/2025
|
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , June 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 06/05/2025
|
West Pharmaceutical Services, Inc. (WST), Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , June 5, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) have opportunity to lead the securities fraud class action lawsuit.
- 06/05/2025
|
Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Levi & Korsinsky Represents Shareholders
- NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151807&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.
- 06/05/2025
|
ROSEN, SKILLED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
- NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
- 06/05/2025
|
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 – WST
- NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
- 06/05/2025
|
WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 31, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151094&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.
- 05/31/2025
|
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 31, 2025 / WHY: New York, N.Y., May 31, 2025.
- 05/31/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
- NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151069&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.
- 05/30/2025
|
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , May 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. So what: If you purchased West Pharmaceutical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 05/30/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151042&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.
- 05/30/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151033&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/30/2025
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 30, 2025 / WHY: New York, N.Y., May 30, 2025.
- 05/30/2025
|
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) - July 7, 2025 Deadline to Join – Contact Levi & Korsinsky
- NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit.
- 05/30/2025
|
Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151018&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.
- 05/30/2025
|
WST Investors Have the Opportunity to Lead the West Pharmaceutical Services Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In West To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , May 30, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST) and reminds investors of the July 7, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- 05/30/2025
|
Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. (WST) - Recover Losses - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150985&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.
- 05/30/2025
|
3 Dividend Aristocrats Wall Street Says Can Soar 48% in 2025
- Nucor (NUE), Albemarle (ALB), and West Pharmaceutical Services (WST) have provided reliable dividends and growth, and Wall Street sees them growing even more over the next year.
- 05/30/2025
|
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about pending Class Action - WST
- NEW YORK , May 30, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 05/30/2025
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
- NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
- 05/29/2025
|
The Gross Law Firm Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 05/29/2025
|
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? Levi & Korsinsky Urges Investors to Act Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150723&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.
- 05/29/2025
|
WST ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against West Pharmaceutical Services, Inc. - July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 29, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150647&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.
- 05/29/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/29/2025
|
Contact The Gross Law Firm by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc.(WST)
- NEW YORK , May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 05/29/2025
|
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150620&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.
- 05/28/2025
|
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK, NY / ACCESS Newswire / May 28, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 05/28/2025
|
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150604&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.
- 05/28/2025
|
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- LOS ANGELES , May 28, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). IF YOU SUFFERED A LOSS ON YOUR WEST INVESTMENTS, CLICK HERE BEFORE JULY 7, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 05/28/2025
|
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150563&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.
- 05/28/2025
|
WST Investors Have the Opportunity to Lead the West Pharmaceutical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In West To Contact Him Directly To Discuss Their Options
- 05/28/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/28/2025
|
Shareholders of West Pharmaceutical Services, Inc. (WST): Protect Your Rights Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 28, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150471&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.
- 05/28/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/28/2025
|
Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) – Join by July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150418&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.
- 05/27/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST) and certain of its officers.
- 05/27/2025
|
WST LAWSUIT ALERT: Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. Investors - Lead Plaintiff Deadline July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150410&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.
- 05/27/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150400&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/27/2025
|
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / WHY: New York, N.Y., May 27, 2025.
- 05/27/2025
|
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150385&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.
- 05/27/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150363&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.
- 05/27/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/27/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150301&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.
- 05/27/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/27/2025
|
West Pharmaceutical Services, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
- NEW YORK , May 27, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 05/27/2025
|
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today
- NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150269&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.
- 05/26/2025
|
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
- NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”), of the important July 7, 2025 lead plaintiff deadline.
- 05/26/2025
|
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today
- NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150251&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.
- 05/26/2025
|
ROSEN, NATIONAL TRIAL LAWYERS, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the important July 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased West common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 05/26/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK , May 26, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/26/2025
|
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150185&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.
- 05/26/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/26/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
- NEW YORK, NY / ACCESS Newswire / May 25, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=150148&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.
- 05/25/2025
|
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 25, 2025 / WHY: New York, N.Y., May 25, 2025.
- 05/25/2025
|
Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) - Join by July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149440&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST) and certain of its officers.
- 05/20/2025
|
69 May Aristocrats: Buy 1 Of 38 "Safer" Dividend Dogs
- Many S&P 500 Dividend Aristocrats remain overvalued, but select high-yield 'Dogs' like Realty Income and Amcor offer attractive entry points for income investors. Analyst forecasts suggest the top ten Aristocrat Dogs could deliver 16% to 38% net gains by May 2026, with average risk below the market. Caution: Fourteen Aristocrats have negative free cash flow margins, making their dividends less secure despite high yields—focus on 'safer' picks like Hormel.
- 05/20/2025
|
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149416&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- BENSALEM, Pa. , May 20, 2025 /PRNewswire/ -- The Law Offices of Howard G.
- 05/20/2025
|
ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST
- NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 7, 2025.
- 05/20/2025
|
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149409&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149389&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
WST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”), have until Monday, July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutical class action lawsuit charges West Pharmaceutical and certain of West Pharmaceutical's current and former top executives with violations of the Securities Exchange Act of 1934.
- 05/20/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky to Join Class Action Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149388&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK , May 20, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/20/2025
|
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149351&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
July 7, 2025 Deadline: Join Class Action Lawsuit Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149345&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/20/2025
|
Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
- NEW YORK , May 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 05/20/2025
|
Class Action Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149277&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , May 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
- 05/19/2025
|
The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - WST
- NEW YORK , May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 05/19/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
- NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc." or the "Company") (NYSE: WST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of West Pharmaceutical Services, Inc. investors who were adversely affected by alleged securities fraud between February 16, 2023 and February 12, 2025.
- 05/19/2025
|
West Pharmaceutical (WST) Upgraded to Buy: Here's What You Should Know
- West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 05/19/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149227&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/19/2025
|
Does West Pharmaceutical (WST) Have the Potential to Rally 31.09% as Wall Street Analysts Expect?
- The average of price targets set by Wall Street analysts indicates a potential upside of 31.1% in West Pharmaceutical (WST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 05/19/2025
|
July 7, 2025 Deadline Approaching: Join Class Action Against West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149160&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) Investors - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149144&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/19/2025
|
Class Action Lawsuit Alert: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. (WST) Investors of July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149117&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
WST INVESTOR ALERT: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO , May 19, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, all dates inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v.
- 05/19/2025
|
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149110&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Before July 7, 2025 to Join Class Action
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149084&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , May 18, 2025 /PRNewswire/ -- Attorney Advertising --Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/18/2025
|
Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149062&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
- 05/18/2025
|
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Over Securities Violations - Contact Levi & Korsinsky Today
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149014&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights – WST
- NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST).
- 05/15/2025
|
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148717&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.
- 05/15/2025
|
Deadline Approaching: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFFICES OF HOWARD G. S.
- 05/15/2025
|
Investors in West Pharmaceutical Services, Inc. (WST): Protect Your Rights - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148698&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.
- 05/15/2025
|
Securities Lawsuit Alert: West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 15, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148629&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.
- 05/15/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/15/2025
|
WST LAWSUIT ALERT: The Gross Law Firm Notifies West Pharmaceutical Services, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK , May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 05/15/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 – Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148589&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/14/2025
|
Contact Levi & Korsinsky by July 7, 2025 to Join Class Action Against West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148568&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.
- 05/14/2025
|
WST Investors Have Opportunity to West Pharmaceutical Services, Inc. Securities Fraud Lawsuit
- NEW YORK , May 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
- 05/14/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Join Class Action Before July 7, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148560&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/14/2025
|
WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
- SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25-cv-02285 (E.D. Pa.), the West Pharmaceutical class action lawsuit charges West Pharmaceutical as well as certain of West Pharmaceutical's current and former top executives with violations of the Securities Exchange Act of 1934.
- 05/14/2025
|
Join Class Action to Recover Losses from West Pharmaceutical Services, Inc. (WST) - Contact Levi & Korsinsky Before July 7, 2025
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148552&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.
- 05/14/2025
|
Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
- LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action.
- 05/14/2025
|
Levi & Korsinsky Notifies West Pharmaceutical Services, Inc. (WST) Shareholders of Class Action Lawsuit and July 7, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148471&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.
- 05/14/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/14/2025
|
Recover Investment Losses: Levi & Korsinsky Files Class Action Against West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148396&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq.
- 05/14/2025
|
WST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/14/2025
|
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- NEW YORK, NY / ACCESS Newswire / May 13, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148317&wire=1 or contact Joseph E. Levi, Esq.
- 05/13/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or “the Company”) (NYSE: WST) and certain of its officers.
- 05/13/2025
|
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights - WST
- NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148205&wire=1 or contact Joseph E. Levi, Esq.
- 05/12/2025
|
WST Class Action Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the West Pharmaceutical Services, Inc. Class Action
- SAN DIEGO, May 12, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025. West is a medical supplies company that specializes in the development, manufacture, and distribution of elastomer-based supplies for the containment and administration of injectable drugs.
- 05/12/2025
|
Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc. (WST) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148194&wire=1 or contact Joseph E. Levi, Esq.
- 05/12/2025
|
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148133&wire=1 or contact Joseph E. Levi, Esq.
- 05/12/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK , May 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE: WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/12/2025
|
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact The Gross Law Firm about pending Class Action - WST
- NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST).
- 05/12/2025
|
Law Offices of Howard G. Smith Encourages West Pharmaceutical Services, Inc. (WST) Investors To Inquire About Securities Fraud Class Action
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). West investors have until July 7, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFF.
- 05/12/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST
- NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148000&wire=1 or contact Joseph E. Levi, Esq.
- 05/12/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/12/2025
|
West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - WST
- NEW YORK , May 12, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 05/12/2025
|
Shareholders That Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky about pending Class Action - WST
- NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147988&wire=1 or contact Joseph E. Levi, Esq.
- 05/12/2025
|
WST INVESTOR NOTICE: West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO , May 12, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services, Inc. (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), have until July 7, 2025 to seek appointment as lead plaintiff of the West Pharmaceutical class action lawsuit. Captioned New England Teamsters Pension Fund v.
- 05/12/2025
|
WST INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: West Pharmaceutical business & prospects, resulting in its stock trading at inflated prices.
- 05/11/2025
|
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST
- NEW YORK, NY / ACCESS Newswire / May 11, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147897&wire=1 or contact Joseph E. Levi, Esq.
- 05/11/2025
|
WST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK, NY / ACCESS Newswire / May 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE:WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/11/2025
|
West Pharmaceutical Services, Inc. Class Action: Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- NEW YORK, NY / ACCESS Newswire / May 10, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147852&wire=1 or contact Joseph E. Levi, Esq.
- 05/10/2025
|
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
- NEW YORK CITY, NY / ACCESS Newswire / May 10, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or the "Company") (NYSE:WST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
- 05/10/2025
|
Shareholders of West Pharmaceutical Services, Inc. Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your Rights – WST
- NEW YORK, NY / ACCESS Newswire / May 9, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147822&wire=1 or contact Joseph E. Levi, Esq.
- 05/09/2025
|
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK , May 9, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired West securities between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period").
- 05/09/2025
|
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 - WST
- NEW YORK, NY / ACCESS Newswire / May 9, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147782&wire=1 or contact Joseph E. Levi, Esq.
- 05/09/2025
|
An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses
- NEW YORK, NY / ACCESS Newswire / May 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 05/02/2025
|
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
- NEW YORK, NY / ACCESS Newswire / May 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 05/01/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/30/2025
|
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - WST
- NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/29/2025
|
An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses
- NEW YORK, NY / ACCESS Newswire / April 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/25/2025
|
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag
- West Pharmaceutical Services, Inc. WST on Thursday reported first-quarter 2025 adjusted EPS of $1.45, beating the consensus of $1.23.
- 04/24/2025
|
West Pharmaceutical Services, Inc. (WST) Q1 2025 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President and Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Larry Solow - CJS Securities Justin Bowers - Deutsche Bank Michael Ryskin - Bank of America David Windley - Jefferies Daniel Markowitz - Evercore ISI Thomas DeBourcy - Nephron Research Doug Schenkel - Wolfe Research Matt Etoch - Stephens Patrick Donnelly - Citi Matthew Larew - William Blair Kyle Crews - UBS Operator Good day, and thank you for standing by. Welcome to the West Pharmaceutical Services First Quarter 2025 Earnings Conference Call.
- 04/24/2025
|
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit
- West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
- 04/24/2025
|
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.56 per share a year ago.
- 04/24/2025
|
Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST
- NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/24/2025
|
West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies
- West Pharmaceutical Services raised its annual profit forecast on Thursday, anticipating a boost from a weaker dollar to shield it from a potential hit from U.S. President Donald Trump's tariffs.
- 04/24/2025
|
West Announces Leadership Changes
- Bernard J. Birkett Announces Intention to Retire from West, Company Initiates Search for a Successor Shane Campbell Appointed Senior Vice President, Chief Proprietary Segment Officer EXTON, Pa. , April 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive leadership changes as part of its succession planning process.
- 04/24/2025
|
West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
- - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
- 04/24/2025
|
Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings?
- West Pharmaceutical Services' first-quarter results are likely to reflect growth amid pharma stabilization, biologics rebound & contract manufacturing gains.
- 04/22/2025
|
WST ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by West Pharmaceutical Services, Inc.
- NEW YORK, NY / ACCESS Newswire / April 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/21/2025
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/18/2025
|
Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline
- West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/17/2025
|
West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/17/2025
|
An Investigation Has Commenced on Behalf of West Pharmaceutical Services, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your WST Losses
- NEW YORK, NY / ACCESS Newswire / April 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/16/2025
|
West Pharmaceutical Services, Inc. Being Investigated on Behalf of West Pharmaceutical Services, Inc. Investors. Contact Levi & Korsinsky For Details.
- NEW YORK, NY / ACCESS Newswire / April 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/15/2025
|
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
- NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/14/2025
|
WST ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of West Pharmaceutical Services, Inc. Shareholders Who Lost Money
- NEW YORK, NY / ACCESS Newswire / April 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/11/2025
|
Shareholders that lost money on West Pharmaceutical Services, Inc.(WST) should contact Levi & Korsinsky about Securities Fraud Investigation - WST
- NEW YORK, NY / ACCESS Newswire / April 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/10/2025
|
West to Host First-Quarter 2025 Conference Call
- EXTON, Pa. , April 10, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 24, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 04/10/2025
|
Investors who lost money on West Pharmaceutical Services, Inc. should contact Levi & Korsinsky about an ongoing investigation - WST
- NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/09/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESS Newswire / April 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/08/2025
|
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
- NEW YORK, NY / ACCESS Newswire / April 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/07/2025
|
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
- NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/04/2025
|
ATTENTION WST SHAREHOLDERS: Investors who Lost Money on West Pharmaceutical Services, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
- NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/03/2025
|
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST
- NEW YORK, NY / ACCESS Newswire / April 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/02/2025
|
Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST
- NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 04/01/2025
|
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
- NEW YORK, NY / ACCESS Newswire / March 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/31/2025
|
West Pharmaceutical Services, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - WST
- NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/28/2025
|
WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment
- NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/27/2025
|
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/26/2025
|
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST
- NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/25/2025
|
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST
- NEW YORK, NY / ACCESS Newswire / March 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/24/2025
|
Levi & Korsinsky Reminds Shareholders of an Investigation into West Pharmaceutical Services, Inc. (WST) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/21/2025
|
West Pharmaceutical Services, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - WST
- NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/20/2025
|
Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST
- NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/19/2025
|
West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/18/2025
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate West Pharmaceutical Services, Inc. (WST) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESS Newswire / March 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/17/2025
|
Buy 2 March S&P 500 Dividend Aristocrats Out Of 37 'Safer'
- Four of the ten lowest-priced Dividend Aristocrats, including Franklin Resources and Realty Income, are ready to buy with annual dividends exceeding their single share prices. Analysts forecast 15.93% to 26.49% net gains for top-ten Aristocrat Dogs by March 2026, with Federal Realty and Stanley Black & Decker leading. A market correction of 65% could make all top-yield Aristocrats fair-priced, with dividends from $1K invested meeting or exceeding their single share prices.
- 03/14/2025
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / March 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/14/2025
|
Shareholders that Lost Money on West Pharmaceutical Services, Inc. (WST) Should Contact Levi & Korsinsky About Securities Fraud Investigation - WST
- NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/13/2025
|
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - WST
- NEW YORK, NY / ACCESS Newswire / March 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/12/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / March 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/11/2025
|
West Pharmaceutical: Remains A Strong Long-Term Prospect
- West Pharmaceutical Services has faced a challenging year, underperforming against the index, with declining volumes, margins, and returns, but remains a strong long-term investment. The company's high-value products segment, driven by GLP-1 medications and biologics, is expected to boost margins and returns significantly. Despite poor timing in share buybacks and management concerns, West's valuation suggests a potential 12.8% annual return, making it a buy.
- 03/11/2025
|
Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - WST
- NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/06/2025
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa. , March 5, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2025 at 11:00 AM ET. It will also present at the KBCM Healthcare Forum on Wednesday, March 19, 2025 at 1:30 PM ET.
- 03/05/2025
|
Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/04/2025
|
Lost Money on West Pharmaceutical Services, Inc. (WST)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK, NY / ACCESS Newswire / March 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 03/03/2025
|
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 02/28/2025
|
Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST)
- NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 02/27/2025
|
West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - WST
- NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 02/26/2025
|
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 02/25/2025
|
West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 02/24/2025
|
West Pharmaceutical Services, Inc. (WST) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West Pharmaceutical Services, Inc. ("West Pharmaceutical Services, Inc.") (NYSE:WST) concerning possible violations of federal securities laws. On February 12, 2025, West reported positive 4Q 2024 financial results but announced full year 2025 guidance that was well below analysts' expectations.
- 02/21/2025
|
West Announces Second-Quarter Dividend
- EXTON, Pa. , Feb. 20, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2025 dividend of $0.21 per share. The dividend will be paid on May 7, 2025, to shareholders of record as of April 30, 2025.
- 02/20/2025
|
West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities
- The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently, did not like the bottom-line results nor the uninspiring guidance for 2025. Still, West should not be overlooked, and there may be opportunities if the share price continues to rebound after a market overreaction.
- 02/17/2025
|
Final Trade: WST, BTC, GLD, ALT
- The final trades of the day with the Fast Money traders.
- 02/14/2025
|
Is WST Stock Undervalued At $200?
- West Pharmaceutical Services, a global provider of solutions for drugs, biologics, gene therapies, and consumer healthcare products, recently announced its Q4 results, surpassing analysts' expectations for both revenue and earnings. The company reported sales of $749 million and adjusted earnings per share of $1.82, compared to $740 million and $1.73, respectively.
- 02/14/2025
|
West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President & Chief Executive Officer Bernard Birkett - Senior Vice President & Chief Financial Officer Conference Call Participants Michael Ryskin - BofA Global Research Lawrence Solow - CJS Securities Patrick Donnelly - Citigroup Inc. Paul Knight - KeyBanc Capital Markets Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank David Windley - Jefferies Jacob Johnson - Stephens Inc. Operator Thank you for standing by and welcome to West Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 02/13/2025
|
West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin
- West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 that was well below expectations.
- 02/13/2025
|
West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance
- On Thursday, West Pharmaceutical Services, Inc. WST reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72.
- 02/13/2025
|
West Pharmaceutical forecasts 2025 results below expectations, shares drop
- West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, sending its shares down 18% premarket.
- 02/13/2025
|
West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.83 per share a year ago.
- 02/13/2025
|
West Announces Fourth-Quarter and Full-Year 2024 Results
- - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
- 02/13/2025
|
Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings?
- West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 22.52%.
- 02/10/2025
|
West to Host Fourth-Quarter and Full-Year 2024 Conference Call
- EXTON, Pa. , Jan. 30, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 01/30/2025
|
West Announces First-Quarter Dividend
- EXTON, Pa. , Jan. 28, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share. The dividend will be paid on February 11, 2025, to shareholders of record as of February 7, 2025.
- 01/28/2025
|
West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack
- EXTON, Pa. , Jan. 22, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the introduction of Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures in a new nested format available in multiple configurations at this year's Pharmapack event in Paris, France. This marks West's latest product offering supporting the needs of advanced therapies, one of the fastest growing areas, driven by continued innovation in cell and gene therapy treatments.
- 01/22/2025
|
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
- WST continues to gain momentum due to its strength in the Pharma market unit. However, the decline across its Generics and Biologics business units is concerning.
- 01/20/2025
|
Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth
- Seeking Alpha's Quant Valuation and Growth Grades identify 6 blue-chip stocks with extremely high valuations matched against limited operating growth potential. Costco, Cencora, West Pharmaceutical Services, Danaher, Madison Square Garden Sports, and Estée Lauder appear to be at risk of disappointing investors in 2025. Weakening technical performance vs. the S&P 500 is part of the bearish sell/avoid equation for each since summer.
- 01/13/2025
|
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference
- EXTON, Pa. , Jan. 6, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Cindy Reiss-Clark, Sr. VP and Chief Commercial Officer; Chad Winters, VP of Finance and Chief Accounting Officer; and John Sweeney, VP of Investor Relations, will present at the CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference on January 14, 2025 at 10:15 a.m. ET. A live audio webcast will be available via the Investors section of our website, www.westpharma.com.
- 01/06/2025
|
LH vs. WST: Which Stock Is the Better Value Option?
- Investors interested in Medical - Dental Supplies stocks are likely familiar with Labcorp (LH) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?
- 01/03/2025
|
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
- WST continues to gain momentum due to its strength in the Pharma market unit. However, the decline across its Generics and Biologics business units is concerning.
- 12/20/2024
|
West Elects New Director to the Board
- EXTON, Pa. , Dec. 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Janet Haugen as its newest member. With the addition of Ms.
- 12/11/2024
|
3 Dividend Gems You Didn't Know Could Build Lasting Wealth
- Over the next 25 years, $124 trillion in inheritances will be transferred, reshaping wealth distribution and offering new investment opportunities for younger generations. Three dividend growth companies on my watch list have impressive potential, enjoying strong secular growth. While these companies may not be “mainstream,” their solid business models and growth prospects make them excellent picks for long-term investors.
- 12/08/2024
|
MMSI or WST: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
- 11/29/2024
|
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
- WST continues to gain momentum due to its strength in the Pharma market unit. However, decline across its Generics and Biologics business units is concerning.
- 11/19/2024
|
Final Trade: West Pharma, Cameco, iShares Biotechnology ETF and Applied Digital Corp
- The final trades of the day with the Fast Money traders.
- 11/15/2024
|
17 Upcoming Dividend Increases
- This week, 17 companies with an average dividend increase of 8.3% are highlighted, emphasizing consistent dividend growth and outperforming benchmarks. My investment strategy focuses on buying, holding, and adding companies with consistent dividend increases and superior performance compared to benchmarks. The list is created using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ, featuring companies with at least five years of dividend growth.
- 11/06/2024
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa. , Oct. 29, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following conferences: UBS Global Healthcare Conference in Rancho Pablos Verdes, California, on November 12, 2024 at 3:30 PM PST Jefferies Healthcare Conference in London, UK on Tuesday, November 19, 2024 at 1:00 PM GMT Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21, 2024 at 10:00 AM CST A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.
- 10/29/2024
|
The Zacks Analyst Blog The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International
- The Gorman-Rupp, Kontoor Brands, Kontoor Brands and Standex International are included in this Analyst Blog.
- 10/29/2024
|
Buy These 4 Stocks With New Dividend Hikes Amid Market Volatility
- Stocks like GRC, KTB, WST and SXI recently announced dividend hikes.
- 10/28/2024
|
West Pharmaceutical Services, Inc. (WST) Q3 2024 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2024 Results Earnings Conference Call October 24, 2024 9:00 AM ET Company Participants John Sweeney - Vice President, Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Inc. Lawrence Solow - CJS Securities Michael Ryskin - BofA Global Research David Windley - Jefferies Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank Thomas DeBourcy - Nephron Research Operator Good day and thank you for standing by. Welcome to the Q3 2024 West Pharmaceutical Services Earnings Conference Call.
- 10/24/2024
|
West Pharmaceutical's Q3 Performance Shows Rising Demand For Syringes, Company Boosts Annual Forecast And Dividend
- On Thursday, West Pharmaceutical Services, Inc. WST reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50.
- 10/24/2024
|
West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance
- WST's third-quarter results reflect a recovery in the Proprietary Products segment following elevated customer destocking, hurting sales in the second quarter.
- 10/24/2024
|
West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $2.16 per share a year ago.
- 10/24/2024
|
West Pharmaceutical raises annual profit forecast on demand for medical supplies
- West Pharmaceutical Services raised its annual profit forecast on Thursday, after beating Wall Street estimates for quarterly revenue and profit, banking on rising demand for cartridges and syringes used to manufacture injectable therapies.
- 10/24/2024
|
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend
- - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
- 10/24/2024
|
West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference
- EXTON, Pa. , Oct. 22, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ to showcase its leadership and expertise on industry challenges and trends in packaging and containment. "With the rise of biologic drugs, injectables are the fastest growing drug segment today, bringing with it new challenges of complex molecules and treatment requirements," says Atul Patel, Vice President, Delivery Devices at West.
- 10/22/2024
|
What's in Store for West Pharmaceutical in Q3 Earnings?
- WST's third-quarter 2024 results are likely to reflect weakness in its Proprietary Products business. Unfavorable currency movements might have hurt the top and bottom lines.
- 10/21/2024
|
Earnings Preview: West Pharmaceutical Services (WST) Q3 Earnings Expected to Decline
- West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/17/2024
|
West to Host Third-Quarter 2024 Conference Call
- EXTON, Pa. , Oct. 10, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 24, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 10/10/2024
|
West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
- EXTON, Pa. , Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center, a part of the Temple University Health System. This award recognizes companies, individuals, and initiatives which nurture philanthropic, ethical and community-based ventures.
- 10/09/2024
|
West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
- EXTON, Pa. , Oct. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPHI Worldwide in Milan, Italy to showcase leadership and expertise on industry challenges and trends in packaging and containment. This year, West will highlight its industry expertise through a technical-focused presentation: Examining Contamination Control Strategy in Primary Packaging as part of EU GMP Annex 1- Wednesday, October 9 | 2:15 - 2:40 p.m.
- 10/07/2024
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , Sept. 5, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Global Healthcare Conference in London, UK on Wednesday, September 18, 2024, at 9:55 AM BST.
- 09/05/2024
|
Final Trade: WST, OIH, META, GOOGL
- The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
- 07/26/2024
|
West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)
- West Pharmaceutical Q2'24 results missed expectations, with lower revenues and EPS missing guidance, impacted by destocking and poor sales in various segments. Management remains optimistic for the back half of the year, with capital investments to support growth, but cash flow concerns and high valuation pose risks. Despite the recent drop in WST share price, the company's high valuation and uncertain cash flow outlook make it unattractive for investment at this time.
- 07/25/2024
|
West Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View
- West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.
- 07/25/2024
|
West Pharmaceutical Services (WST) Q2 Earnings and Revenues Miss Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.52 per share, missing the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $2.11 per share a year ago.
- 07/25/2024
|
West Pharmaceutical lowers full-year sales, profit forecast on subdued demand
- West Pharmaceutical Services cut its annual profit and sales forecast on Thursday, on lower demand for its medical equipment used in making injectable drugs as biotech customers worked through their existing inventories.
- 07/25/2024
|
West Announces Second-Quarter 2024 Results
- - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
- 07/25/2024
|
The Secret's Out - 3 Fantastic Dividend Growth Stocks You Need To Know
- Stocks outperform cash, but most wealth comes from a few standout companies. More than half of individual stocks lose money long-term, highlighting the need for careful selection. Investors can build wealth with stocks offering essential products and steady growth. Success doesn't require high-risk choices but finding solid, reliable performers. The article explores three promising stocks flying under the radar, each excelling in critical industries. These picks demonstrate how strategic investments can yield impressive returns.
- 07/24/2024
|
24 Barron's Pro-Picked 2024 Mid-Year Dividend Dogs: Buy 2 In July
- Barron's Mid-Year 2024 Pro Picks revealed by panelists for potential investment opportunities. Barron's interviews of eleven financial industry Roundtable-pros tapped 48 predictions. Twelve non-ADR foreign stocks and six funds were dropped by YCharts screens, and six selections paid no dividends, leaving 24 in the final pool. The Barron's list tracked by YCharts as of 7/17/24 projected ten top analyst-estimated net gains from WST, ASML, PBR, RUSHA & topped by SLB ranging 19.46%-35.09%.
- 07/23/2024
|
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
- West Pharmaceutical's (WST) second-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
- 07/22/2024
|
West to Host Second-Quarter 2024 Conference Call
- EXTON, Pa. , July 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter financial results before the market opens on Thursday, July 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 07/11/2024
|
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 06/21/2024
|
4 Stocks to Buy Amid Dental Supplies Industry Challenges
- Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include MCK, WST, ALGN and HSIC.
- 06/14/2024
|
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
- CZ's Nested Vials are designed to meet the exterior dimensions of glass standard ISO 8362-1 and offer broad compatibility with various aseptic fill-finish equipment available in the market. EXTON, Pa.
- 05/29/2024
|
10 Dividend Growth Stocks: May 2024
- In this series, I rank a selection of dividend growth stocks in Dividend Radar and present the ten top-ranked stocks for consideration. To rank stocks, I do a quality assessment and sort stocks by quality scores, breaking ties with additional metrics. This month, I'm presenting candidates with 5-year earnings growth rates and 5-year trailing total returns above 17%. The candidates have strong total return prospects.
- 05/28/2024
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , May 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 44th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4, 2024 at 8:00 AM CT. A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com.
- 05/28/2024
|
Q2 2024 EPS Estimates for West Pharmaceutical Services, Inc. (NYSE:WST) Cut by Analyst
- West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) – Stock analysts at Zacks Research dropped their Q2 2024 earnings estimates for West Pharmaceutical Services in a research note issued on Thursday, May 16th. Zacks Research analyst I. Bandyopadhyay now expects that the medical instruments supplier will post earnings per share of $1.77 for the quarter, down from their prior forecast of $1.97. The consensus estimate for West Pharmaceutical Services’ current full-year earnings is $7.76 per share. Zacks Research also issued estimates for West Pharmaceutical Services’ Q3 2024 earnings at $2.10 EPS, FY2024 earnings at $7.66 EPS, Q3 2025 earnings at $2.42 EPS and FY2025 earnings at $9.06 EPS. Several other analysts also recently commented on the stock. UBS Group dropped their target price on shares of West Pharmaceutical Services from $400.00 to $375.00 and set a “neutral” rating on the stock in a report on Friday, February 16th. StockNews.com lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a report on Friday, February 16th. Jefferies Financial Group raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and upped their target price for the stock from $323.00 to $536.00 in a research note on Wednesday, February 7th. Finally, KeyCorp lifted their price target on West Pharmaceutical Services from $440.00 to $470.00 and gave the company an “overweight” rating in a research note on Tuesday, February 13th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, West Pharmaceutical Services currently has a consensus rating of “Moderate Buy” and an average price target of $435.20. Read Our Latest Report on West Pharmaceutical Services West Pharmaceutical Services Trading Up 0.4 % NYSE:WST opened at $355.64 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.61 and a quick ratio of 1.95. The business’s 50-day simple moving average is $378.36 and its 200-day simple moving average is $364.18. West Pharmaceutical Services has a fifty-two week low of $310.42 and a fifty-two week high of $415.73. The stock has a market capitalization of $25.90 billion, a PE ratio of 46.92, a price-to-earnings-growth ratio of 6.26 and a beta of 1.05. West Pharmaceutical Services (NYSE:WST – Get Free Report) last posted its earnings results on Thursday, April 25th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.27. West Pharmaceutical Services had a return on equity of 20.57% and a net margin of 19.42%. The firm had revenue of $695.40 million for the quarter, compared to analyst estimates of $670.62 million. During the same period in the previous year, the company posted $1.98 earnings per share. The company’s revenue for the quarter was down 3.0% on a year-over-year basis. West Pharmaceutical Services Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 7th. Shareholders of record on Wednesday, July 31st will be issued a $0.20 dividend. The ex-dividend date is Wednesday, July 31st. This represents a $0.80 annualized dividend and a dividend yield of 0.22%. West Pharmaceutical Services’s dividend payout ratio is currently 10.55%. Insider Buying and Selling at West Pharmaceutical Services In other news, CEO Eric Mark Green sold 66,000 shares of West Pharmaceutical Services stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total value of $24,198,900.00. Following the completion of the sale, the chief executive officer now directly owns 152,908 shares in the company, valued at $56,063,718.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CAO Chad Winters sold 815 shares of the firm’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $358.82, for a total value of $292,438.30. Following the sale, the chief accounting officer now directly owns 1,309 shares in the company, valued at approximately $469,695.38. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Eric Mark Green sold 66,000 shares of the company’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $366.65, for a total transaction of $24,198,900.00. Following the transaction, the chief executive officer now owns 152,908 shares of the company’s stock, valued at $56,063,718.20. The disclosure for this sale can be found here. Insiders have sold a total of 139,978 shares of company stock valued at $50,852,672 in the last three months. 0.53% of the stock is currently owned by company insiders. Institutional Trading of West Pharmaceutical Services A number of hedge funds have recently made changes to their positions in the company. Fidelis Capital Partners LLC acquired a new position in West Pharmaceutical Services in the 1st quarter valued at approximately $27,000. Quarry LP boosted its holdings in West Pharmaceutical Services by 155.3% in the fourth quarter. Quarry LP now owns 97 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 59 shares during the last quarter. Hazlett Burt & Watson Inc. acquired a new stake in West Pharmaceutical Services during the 1st quarter valued at approximately $40,000. Northwest Investment Counselors LLC bought a new position in West Pharmaceutical Services during the 1st quarter worth approximately $40,000. Finally, Planned Solutions Inc. acquired a new position in shares of West Pharmaceutical Services in the 4th quarter worth approximately $39,000. 93.90% of the stock is owned by institutional investors and hedge funds. West Pharmaceutical Services Company Profile (Get Free Report) West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
- 05/20/2024
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT. A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com.
- 04/30/2024
|
West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2024 Earnings Conference Call April 25, 2024 9:00 AM ET Company Participants Quintin Lai - Vice President, Strategy and Investor Relations Eric Green - President and Chief Executive Officer Bernard Birkett - Senior Vice President, Chief Financial and Operations Officer Conference Call Participants Matt Larew - William Blair Jacob Johnson - Stephens Paul Knight - KeyBanc Michael Ryskin - Bank of America Justin Bowers - Deutsche Bank David Windley - Jefferies Larry Solow - CJS Securities Operator Good day, and thank you for standing by. Welcome to West Pharmaceutical Services First Quarter 2024 Earnings Conference Call.
- 04/25/2024
|
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
- West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
- 04/25/2024
|
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.98 per share a year ago.
- 04/25/2024
|
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
- West Pharmaceutical Services on Thursday beat quarterly profit estimates and raised its annual profit forecast, banking on rising demand for cartridges and syringes used to manufacture injectable therapies.
- 04/25/2024
|
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
- - Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa.
- 04/25/2024
|
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
- West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/24/2024
|
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
- West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
- 04/22/2024
|
Ex-Dividend Reminder: Lennar, Lowe's And West Pharmaceutical
- On 4/23/24, Lennar, Lowe's Companies and West Pharmaceutical Services, will all trade ex-dividend for their respective upcoming dividends. Lennar will pay its quarterly dividend of $0.50 on 5/8/24, Lowe's Companies will pay its quarterly dividend of $1.10 on 5/8/24, and West Pharmaceutical Services will pay its quarterly dividend of $0.20 on 5/1/24.
- 04/19/2024
|
West Pharmaceutical Services (WST) Expected to Beat Earnings Estimates: Should You Buy?
- West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/18/2024
|
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 04/17/2024
|
West to Host First-Quarter 2024 Conference Call
- EXTON, Pa. , April 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 04/11/2024
|
3 Pharma Stocks to Sell in March Before They Crash & Burn
- Recent trends in the stock market have seen a shift in investor interest from tech giants, known as the Magnificent 7, towards pharmaceutical companies, particularly those involved in weight-loss drugs. But, it's important to identify which pharma stocks to sell before they plummet, as not all will benefit equally from the hype.
- 03/14/2024
|
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 03/14/2024
|
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
- West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 03/13/2024
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa. , Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET. It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET.
- 02/28/2024
|
Why West Pharma Is Far From Done
- West Pharmaceutical Services is a global manufacturer specializing in advanced containment and delivery systems for injectable drugs and healthcare products. The company has a strong focus on high-value products and strategic collaborations, positioning it for future growth in the healthcare sector. Despite current challenges and a somewhat lofty valuation, projected earnings growth suggests the potential for significant long-term returns.
- 02/27/2024
|
West Announces Second-Quarter 2024 Dividend
- EXTON, Pa. , Feb. 20, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2024 dividend of $0.20 per share. The dividend will be paid on May 1, 2024, to shareholders of record as of April 24, 2024.
- 02/20/2024
|
West Pharmaceutical (WST) Beats on Q4 Earnings, HVP Drives Sales
- West Pharmaceutical's (WST) fourth-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
- 02/15/2024
|
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
- 02/15/2024
|
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/15/2024
|
West Pharmaceutical Stock Tumbles on Weak 2024 Outlook
- The company had warned in recent months that its clients were slowing down their purchasing.
- 02/15/2024
|
West Pharmaceutical Services (WST) Beats Q4 Earnings Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.77 per share a year ago.
- 02/15/2024
|
Medical equipment maker West Pharmaceutical forecasts weak annual results
- West Pharmaceutical Services forecast full-year results below analysts' estimates on Thursday after the company missed fourth-quarter revenue expectations, hurt by weak demand for its medical equipments used to make COVID-19 vaccines.
- 02/15/2024
|
BDX or WST: Which Is the Better Value Stock Right Now?
- Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?
- 02/13/2024
|
What's in Store for West Pharmaceutical (WST) in Q4 Earnings?
- West Pharmaceutical's (WST) fourth-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
- 02/13/2024
|
Insights Into West Pharmaceutical (WST) Q4: Wall Street Projections for Key Metrics
- Get a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
- 02/12/2024
|
Final Trades: West Pharma, Sonos, Thermo Fisher and TransDigm
- Today's “Halftime Report” Investment Committee, Steve Weiss, Joe Terranova, Brian Belski and Karen Firestone give their top picks to watch for the second half.
- 02/07/2024
|
West to Host Fourth-Quarter and Full-Year 2023 Conference Call
- EXTON, Pa. , Feb. 1, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2023 financial results before the market opens on Thursday, February 15, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 02/01/2024
|
West Pharmaceutical Services: A Solid Buy For Long-Term Investors
- Century-old West Pharmaceutical Services has a strong history of growing its top and bottom lines. It remains a growth stock, with very good margins, seasoned management and a proven strategy. It will be overvalued for short-term investors, but fairly priced for investors with medium and long-term horizons.
- 01/09/2024
|
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 01/04/2024
|
MMSI or WST: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Merit Medical (MMSI) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
- 12/28/2023
|
West Pharmaceutical's (WST) New Launch to Expand Portfolio
- West Pharmaceutical's (WST) latest addition to its portfolio is likely to address the critical need for more drug preparation and delivery options at the point of care.
- 12/05/2023
|
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 11/29/2023
|
Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors
- Need help boosting your long-term portfolio gains? Well, you're in luck.
- 11/14/2023
|
3 Dividend Champions with room for dividend growth
- The World Series champion Texas Rangers recently paid nice dividends for sports bettors. For stock investors, there's a different, more predictable group of dividend payers worth betting on — the Dividend Champions.
- 11/13/2023
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa. , Nov. 1, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at Jefferies Healthcare Conference in London, UK on Tuesday, November 14, 2023 at 10:00 AM GBT. It will also hold a fireside chat at the Stephens Annual Investment Conference in Nashville, TN on Thursday, November 16, 2023 at 8:00 AM CST.
- 11/01/2023
|
5 Stocks to Watch on Recent Dividend Hikes Amid Volatility
- Investors may keep a tab on stocks like WST, SXI, WCN, MPC and EQIX, which have lately hiked their dividend payments.
- 10/27/2023
|
West Pharmaceutical Services, Inc. (WST) Q3 2023 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET Company Participants Quintin Lai - Vice President of Investor Relations Eric Green - President & Chief Executive Officer Conference Call Participants Paul Knight - KeyBanc Capital Markets Larry Solow - CJS Securities Jacob Johnson - Stephens John Sourbeer - UBS Matt Larew - William Blair David Windley - Jefferies Justin Bowers - Deutsche Bank Derik De Bruin - Bank of America Operator Good day, and thank you for standing by. Welcome to the Third Quarter 2023 West Pharmaceutical Services Earnings Conference Call.
- 10/26/2023
|
Here's What Key Metrics Tell Us About West Pharmaceutical (WST) Q3 Earnings
- The headline numbers for West Pharmaceutical (WST) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 10/26/2023
|
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Beat Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.03 per share a year ago.
- 10/26/2023
|
Medical equipment maker West Pharmaceutical raises 2023 profit forecast
- Medical equipment maker West Pharmaceutical Services on Thursday raised its 2023 adjusted profit forecast for a third time, benefiting from a stronger dollar.
- 10/26/2023
|
What's in Store for West Pharmaceutical (WST) in Q3 Earnings?
- West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
- 10/20/2023
|
7 Healthcare Stocks to invest in for a Healthy Future
- One of my favorite sectors will always be the healthcare sector. It is practically a basic need for all human beings and is always in constant development and growth.
- 10/20/2023
|
West Pharmaceutical Services: The Run Might Be Over
- West Pharmaceutical Services, Inc. has experienced a 60% gain in its stock price so far in 2023 but has hit some recent technical headwinds. Insiders have also sold a significant number of shares in August and September, and the stock's free cash flow yield is dwarfed to what is available in short-term treasuries. The stock also seems stretched based on its current P/E and price-to-sales valuation metrics.
- 10/18/2023
|
West to Present on Development of Large Volume Delivery Systems, Self-injection Devices, and Prefillable Syringe Component Expertise at the PDA Conference
- Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa. , Oct. 16, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden to showcase its leadership and expertise on industry challenges and trends in packaging and containment.
- 10/16/2023
|
Final Trades: WST, BIIB, SPY & MDT
- The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
- 10/11/2023
|
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 09/25/2023
|
Which Is A Better Pick – Corning Stock Or West Pharmaceutical Services?
- Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion.
- 09/21/2023
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , Sept. 7, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at Bank of America Global Healthcare Conference in London, UK on Thursday, September 14, 2023 at 10:50 AM BST.
- 09/07/2023
|
The 3 Best Retirement Stocks to Buy Now: September 2023
- Building a well-rounded portfolio is crucial as you plan for financial stability in your retirement. Diversification is critical, ensuring your investments are spread across various sectors and asset types.
- 09/06/2023
|
Reasons to Retain West Pharmaceutical (WST) Stock for Now
- West Pharmaceutical's (WST) strength in its proprietary products segment raises optimism about the stock.
- 08/18/2023
|
West Pharmaceutical (WST) Hits 52-Week High: More Room to Grow?
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 08/16/2023
|
West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics
- West Pharmaceutical Services has seen a 60% rally in its stock price since December 2022, outperforming the S&P 500. Momentum in financials shows a decline in top line sales but strong growth in contract-manufactured revenues and free cash flow. The company has demonstrated the ability to compound value for shareholders and has attractive technical indicators for future growth.
- 08/08/2023
|
Is West Pharmaceutical Services Inc (WST) Fairly Valued?
- The stock of West Pharmaceutical Services Inc ( WST , Financial) has seen a daily gain of 4.13% and a 3-month gain of 6.84%. With an Earnings Per Share (EPS) of 6.86, the question arises: Is the stock fairly valued?
- 08/08/2023
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , Aug. 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the UBS MedTech, Tools and Genomics Summit in Dana Point, CA on Wednesday, August 16, 2023 at 3:00 – 3:45 PM PDT. A live audio webcast will be available in the "Investors" section of the Company's website at www.westpharma.com.
- 08/02/2023
|
West Pharmaceutical (WST) Q2 Earnings Beat, HVP Drives Sales
- West Pharmaceutical's (WST) second-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.
- 07/27/2023
|
West Pharmaceutical Services (WST) Tops Q2 Earnings and Revenue Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.95 per share. This compares to earnings of $2.47 per share a year ago.
- 07/27/2023
|
What's in Store for West Pharmaceutical (WST) in Q2 Earnings?
- West Pharmaceutical's (WST) second-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
- 07/24/2023
|
Worried About Market Froth? Buy These 3 Dividend Stocks
- The stock market has been on an absolute tear this year with the S&P 500 up 19% and the Nasdaq 100 up a whopping 42.6% YTD.
- 07/21/2023
|
4 Factor Dividend Growth Portfolio - Deep Dive Analysis
- My portfolio based on the stock selection methodology of The Dow Jones US Dividend 100 Index has returned 21.72% since its inception 8.5 months ago. This deep dive analysis tested the contribution that each of the 4 factors played on the final return of the portfolio. I performed simple linear regression analysis and single and multi-factor analysis which generated surprising results.
- 07/21/2023
|
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
- Morgan Stanley on Friday lifted its forecast for annual sales of weight-loss drugs to $77 billion, as patient demand for the medicines has outstripped supply and been fueled by a social-media frenzy.
- 07/21/2023
|
5 Stocks to Buy From the Prospering Dental Supplies Industry
- Here we discuss five stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, ALGN, COO, XRAY and PDCO.
- 07/17/2023
|
S&P 500 Reclaims 4,500 Level: 5 Best Stocks in ETF
- The S&P 500 Index reached 4,500 for the first time in more than 15 months We have highlighted five stocks in ETF from different sectors that have gained more than 50% this year and have a Zacks Rank #1 (Strong Buy) or #2 (Buy).
- 07/14/2023
|
West to Host Second-Quarter 2023 Conference Call
- EXTON, Pa. , July 13, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2023 financial results before the market opens on Thursday, July 27, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 07/13/2023
|
West Pharmaceutical (WST) Hits 52-Week High: More Room to Grow?
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 07/03/2023
|
6 Stocks That Have Outperformed Apple This Year
- Apple actually isn't the best performer in the S&P 500 so far this year.
- 06/28/2023
|
Markets Ended the Day Lower, but Up for the Week on Inflation, Fed Optimism
- Markets closed lower for the day, higher for the week on lower inflation, expectations the Fed may be pause or halt interest rate hikes.
- 06/16/2023
|
Markets Little Changed Midday but on Track for Weekly Gains Heading into Holiday
- U.S. equities were little changed at midday on Friday, June 16, 2023, but on track for a winning week heading into the long holiday weekend.
- 06/16/2023
|
Reasons to Add West Pharmaceutical (WST) to Your Portfolio Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
- 06/14/2023
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa. , May 24, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the William Blair 43rd Annual Growth Stock Conference in Chicago, IL on Tuesday, June 6, 2023 at 1:20pm CT. It will also present at the Jefferies Healthcare Conference in New York, NY on Wednesday, June 7, 2023 at 8:00 am ET.
- 05/24/2023
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , May 4, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities 2023 Health Care Conference in Las Vegas, NV, on Thursday, May 11, 2023, at 8:00 am PDT. A live audio webcast will be available in the "Investors" section of the Company's website at www.westpharma.com.
- 05/04/2023
|
West Pharmaceutical (WST) Q1 Earnings Beat, Order Book Strong
- West Pharmaceutical's (WST) first-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.
- 04/27/2023
|
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
- West Pharmaceutical Services (WST) came out with quarterly earnings of $1.98 per share, beating the Zacks Consensus Estimate of $1.67 per share. This compares to earnings of $2.30 per share a year ago.
- 04/27/2023
|
West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?
- Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 04/26/2023
|
3 Dental Supplies Stocks to Buy as Industry Prospects Recover
- Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.
- 04/26/2023
|
What's in Store for West Pharmaceutical (WST) in Q1 Earnings?
- West Pharmaceutical's (WST) first-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
- 04/21/2023
|
BMEZ: Attractive Discount On This Riskier Healthcare Fund
- BMEZ: Attractive Discount On This Riskier Healthcare Fund.
- 04/20/2023
|
BDX vs. WST: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Becton Dickinson (BDX) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?
- 04/14/2023
|
West to Host First-Quarter 2023 Conference Call
- EXTON, Pa. , April 13, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2023 financial results before the market opens on Thursday, April 27, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 04/13/2023
|
What Factors Will Drive S&P 500 Performance This Year?
- Many investors feel a sense of relief after the broad markets rebounded in the first quarter. Some even have a growing sense of optimism as index-tracking exchange-traded funds like the SPDR S&P 500 ETF Trust (NYSEARCA: SPY), Invesco QQQ ETF (NASDAQ: QQQ), and the SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA: DIA) posted gains.
- 04/07/2023
|
BDX or WST: Which Is the Better Value Stock Right Now?
- BDX vs. WST: Which Stock Is the Better Value Option?
- 03/29/2023
|
Healthcare Stocks With at Least 30 Years of Dividend Increases
- While it is not the only factor to consider, the annual dividend can solidify whether a stock will benefit you financially. And among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
- 03/14/2023
|
HSIC or WST: Which Is the Better Value Stock Right Now?
- HSIC vs. WST: Which Stock Is the Better Value Option?
- 03/13/2023
|
Healthcare's Hidden Gem: West Pharmaceutical Services
- West Pharmaceutical Services is far from small, yet still a somewhat hidden healthcare gem. This fast-growing supplier of healthcare products like syringes and deliverables benefits from multiple secular tailwinds and a big business moat.
- 03/13/2023
|
The 5 Best and Worst Performing Large-Cap Stocks in February 2023
- Investing in large-cap stocks is considered one of the best ways to invest in the stock market.
- 03/07/2023
|
West Pharmaceutical: A Growing Company, But Pass On Its Declining Margin Outlook
- WST surprisingly ended FY'22 with positive (YoY) growth. Thanks to its innovative product portfolio and capacity expansion catalyst, the management expects continued growth in its top line in FY'23.
- 03/02/2023
|
My Best Dividend Aristocrats For March 2023
- NOBL started the year off with a gain of 3.23% in January; it is thus far not faring as well in February, but the ETF is still positive year-to-date. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.
- 02/25/2023
|
MMSI vs. WST: Which Stock Is the Better Value Option?
- MMSI vs. WST: Which Stock Is the Better Value Option?
- 02/23/2023
|
West Pharmaceutical Services, Inc. (WST) Q4 2022 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q4 2022 Earnings Conference Call February 16, 2023 9:00 AM ET Company Participants Quintin Lai - VP, Strategy & IR Eric Green - Chair, President & CEO Bernard Birkett - SVP and Chief Financial & Operations Officer Conference Call Participants Lawrence Solow - CJS Securities Matthew Larew - William Blair & Company Jacob Johnson - Stephens Inc. John Sourbeer - UBS Derik De Bruin - Bank of America Merrill Lynch Paul Knight - KeyBanc Capital Markets David Windley - Jefferies Justin Bowers - Deutsche Bank Operator Good day, and thank you for standing by. Welcome to West Pharmaceutical Services Fourth Quarter 2022 Earnings Conference Call.
- 02/16/2023
|
West Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of 27.34% and 8.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/16/2023
|
Why West Pharmaceutical (WST) Might Surprise This Earnings Season
- West Pharmaceutical (WST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/15/2023
|
Could West Pharmaceutical Be a Value Stock?
- The health care industry has several strong tailwinds, especially among companies active in international markets. Wealth is increasing in most of the world, and that means increasing demand for health services.
- 02/09/2023
|
BDX vs. WST: Which Stock Is the Better Value Option?
- BDX vs. WST: Which Stock Is the Better Value Option?
- 02/07/2023
|
West to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences
- EXTON, Pa., Feb. 2, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2022 financial results before the market opens on Thursday, February 16, 2023, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 02/02/2023
|
My Best Dividend Aristocrats For February 2023
- NOBL fell 4.12% in December, which brings the Fund's return for the year to a loss of 6.5%. Thus far this month, through January 25th, the dividend aristocrat ETF is up 1.92% and starting the year on a bright note.
- 01/28/2023
|
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 01/11/2023
|
U.S. Wide-Moat Stocks On Sale: The January 2023 Heat Map
- Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
- 01/05/2023
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , Jan. 5, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 12, 2023, at 9:00 am PST.
- 01/05/2023
|
My Best Dividend Aristocrats For January 2023
- NOBL gained 7.12% in November, which brings the Fund's return for the year to a loss of 2.14%. Thus far this month, through December 23rd, the dividend aristocrat ETF is down 3.47%, bringing its year-to-date return to -5.86%.
- 12/26/2022
|
West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference
- EXTON, Pa. , Dec. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share. The dividend will be paid on February 1, 2023, to shareholders of record as of January 25, 2023.
- 12/13/2022
|
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
- The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
- 11/28/2022
|
My Best Dividend Aristocrats For December 2022
- NOBL gained 10.31% in October, which brings the Fund's return for the year to a loss of 8.96%. Thus far this month, through November 22nd, the dividend aristocrat ETF is up 6.52%, bringing its year-to-date return to -3.03%.
- 11/24/2022
|
7 Dividend Stocks Set to Surge Higher in 2023
- Next year isn't very far away. In less than two months, we'll be ringing in the New Year and making resolutions.
- 11/21/2022
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa. , Nov. 4, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the Jefferies London Healthcare Conference in London, UK on Tuesday, November 15 at 3:50 PM GMT (11:50 AM ET). The Company will also present at the Stephens Annual Investment Conference in Nashville, TN on Thursday, November 17, 2022 at 2:00 PM CT.
- 11/04/2022
|
14 Upcoming Dividend Increases Including A Dividend King
- All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.8% and a median increase of 5.8%.
- 11/03/2022
|
West Pharmaceutical Services, Inc. (WST) Q3 2022 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President-Investor Relations Eric Green – Chief Executive Officer Bernard Birkett – Chief Financial Officer Conference Call Participants Paul Knight – KeyBanc Larry Solow – CJS Securities Derik DeBruin – Bank of America Dave Windley – Jefferies Jacob Johnson – Stephens Operator Good day and thank you for standing by. Welcome to the Q3 2022 West Pharmaceutical Services Earnings Conference Call.
- 10/27/2022
|
Why West Pharmaceutical Services Stock Is Heading South Today
- The company reported disappointing Q3 results.
- 10/27/2022
|
West Pharmaceutical (WST) Q3 Earnings Miss, FY22 View Revised
- West Pharmaceutical's (WST) third-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance.
- 10/27/2022
|
West Pharmaceutical Services (WST) Misses Q3 Earnings and Revenue Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of -4.25% and 5.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/27/2022
|
My Best Dividend Aristocrats For November 2022
- NOBL fell 9.15% in September, which brings the Funds return for the year to a loss of 17.47%. Thus far this month, through October 24th, the dividend aristocrat ETF is up 6.04%, bringing its year-to-date return to -12.49%.
- 10/26/2022
|
What's in Store for West Pharmaceutical (WST) in Q3 Earnings?
- West Pharmaceutical's (WST) third-quarter results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements are likely to hurt the top and bottom lines.
- 10/21/2022
|
Reasons to Retain West Pharmaceutical (WST) in Your Portfolio
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 10/18/2022
|
West to Present on Development of Large Volume Delivery Systems, Self-injection Devices and Prefillable Syringe Component Expertise at the PDA Conference
- Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa. , Oct. 18, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2022 PDA Universe of Pre-Filled Syringes and Injection Devices Conference to showcase its leadership and expertise on industry challenges and trends in packaging and containment.
- 10/18/2022
|
West to Host Third-Quarter 2022 Conference Call
- EXTON, Pa. , Oct. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2022 financial results before the market opens on Thursday, October 27, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 10/13/2022
|
My Best Dividend Aristocrats For October 2022
- NOBL fell 2.78% in August which brings the Funds return for the year to a loss of 9.16%. Thus far, through September 23rd, the dividend aristocrat ETF is down 6.71%, bringing its year-to-date return to -15.25%.
- 09/26/2022
|
Here's Why You Should Retain West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 09/12/2022
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa. , Sept. 8, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the Bank of America Global Healthcare Conference taking place September 15, 2022, in London, UK, at 1:20 pm British Summer Time (8:20 am EDT).
- 09/08/2022
|
West Pharmaceutical Services, Inc.'s (WST) CEO Eric Green on Q2 2022 Results - Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President, Investor Relations Eric Green – Chief Executive Officer Bernard Birkett – Chief Financial Officer Conference Call Participants Derik de Bruin – Bank of America Paul Knight – KeyBanc Larry Solow – CJS Securities Justin Lin – William Blair Jacob Johnson – Stephens Dave Windley – Jefferies Operator Good day, and thank you for standing by. Welcome to the Q2 2022 West Pharmaceutical Services Conference Call.
- 07/28/2022
|
West to Host Second-Quarter 2022 Conference Call
- EXTON, Pa. , July 14, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2022 financial results before the market opens on Thursday, July 28, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 07/14/2022
|
West Pharmaceutical Services: A Great Business At A Lofty Price
- West Pharmaceutical Services has performed extraordinarily well in recent years. The future of the enterprise looks bright and the company will likely continue to fare well in the years to come.
- 07/06/2022
|
Here's Why You Should Retain West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 06/16/2022
|
West Pharmaceutical's (WST) Syringe System to Improve Outcome
- West Pharmaceutical's (WST) new CZ syringe system size is expected to enable a simpler patient experience and aid pharmaceutical companies in providing better access to their products.
- 06/16/2022
|
Here's Why West Pharmaceutical Services (WST) is a Strong Growth Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/23/2022
|
Here's Why You Should Retain West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 05/17/2022
|
West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q1 2022 Earnings Call Transcript
- West Pharmaceutical Services, Inc. (NYSE:WST ) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Quintin Lai - VP, IR Eric Green - President and CEO Bernard Birkett - CFO Conference Call Participants Larry Solow - CJS Securities Justin Lin - William Blair Paul Knight - KeyBanc Jacob Johnson - Stephens Derik De Bruin - Bank of America Dave Windley - Jefferies Operator Good day and thank you for standing by. Welcome to the Q1 2022 West Pharmaceutical Services Earnings Conference Call.
- 04/28/2022
|
West Pharmaceutical (WST) Q1 Earnings Top Estimates, Revenues Lag
- West Pharmaceutical's (WST) first-quarter earnings reflect strength in the Proprietary Products segment and operating margin expansion.
- 04/28/2022
|
West Pharmaceutical Services Shares Slides Post Q1 Results
- West Pharmaceutical Services Inc (NYSE: WST) reported first-quarter FY22 sales growth of 7.4% year-on-year to $720 million, missing the consensus of $720.92 million. Proprietary products segment revenue grew 10.6% Y/Y to $601.3 million.
- 04/28/2022
|
West Pharmaceutical Services (WST) Q1 Earnings Top Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of 5.50% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2022
|
Healthy Dividends: Organic Growth Points North For West Pharmaceutical Services
- West Pharmaceutical Services is becoming a vital component of the healthcare industry. West has provided critical products and services required for COVID-19 vaccines. WST is a "Dividend Aristocrat" and has raised its dividend for 29 consecutive years. However, WST's dividend yield is a trivial 0.21% with a payout ratio of 8.01%.
- 04/26/2022
|
West to Host First-Quarter 2022 Conference Call
- EXTON, Pa. , April 14, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2022 financial results before the market opens on Thursday, April 28, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 04/14/2022
|
Here's Why You Should Retain West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 04/11/2022
|
4 Growth Stocks to Buy and Hold Forever
- These companies are the rare breed that perform well while letting you sleep well at night.
- 04/03/2022
|
3 Lucrative Stocks From the Promising Dental Supplies Industry
- Despite the COVID-19 pandemic-induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 03/29/2022
|
7 Healthcare Stocks to Buy for the Long Term
- When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. The post 7 Healthcare Stocks to Buy for the Long Term appeared first on InvestorPlace.
- 03/21/2022
|
Is There A Better Pick Over West Pharmaceutical Services Stock?
- We believe that Catalent stock, a global solutions provider for drugs, biologics, gene therapies, and consumer healthcare products, currently is an attractive pick over West Pharmaceutical Services, best known for injectable pharmaceutical packaging and delivery systems, given its comparatively.
- 03/11/2022
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa., March 9, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place virtually on March 23, 2022. Management will present at 9:00 a.m.
- 03/09/2022
|
Here's Why You Should Retain West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
- 03/08/2022
|
West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2021 Results - Earnings Call Transcript
- West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2021 Results - Earnings Call Transcript
- 02/17/2022
|
West Pharmaceutical (WST) Q4 Earnings & Revenues Top Estimates
- West Pharmaceutical's (WST) fourth-quarter earnings reflect strength in the Proprietary Products segment and margin expansion.
- 02/17/2022
|
West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of 6.25% and 3.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/17/2022
|
What's in Store for West Pharmaceutical's (WST) Q4 Earnings?
- West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business.
- 02/14/2022
|
West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/10/2022
|
West Pharmaceutical Services (WST) Stock Sinks As Market Gains: What You Should Know
- In the latest trading session, West Pharmaceutical Services (WST) closed at $400.69, marking a -0.01% move from the previous day.
- 02/08/2022
|
West to Host Fourth-Quarter and Full-Year 2021 Conference Call
- EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2021 financial results before the market opens on Thursday, February 17, 2022, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 02/03/2022
|
Here's Why You Should Retain West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Products business. However, forex woes persist.
- 02/01/2022
|
West Pharmaceutical Services (WST) Gains But Lags Market: What You Should Know
- In the latest trading session, West Pharmaceutical Services (WST) closed at $393.22, marking a +0.05% move from the previous day.
- 01/31/2022
|
My Top 15 High Growth Dividend Stocks For January 2022
- I present my top 15 high-growth dividend stocks to consider during the month of January. Last month's list returned 4.65% in December to finish out 2021 with a total return of 33.52%.
- 01/11/2022
|
Dividend Growth Stock Watchlist - January 2022
- There are 23 stocks on my dividend growth watchlist for January 2022. Six of the stocks on my watchlist are currently undervalued based on dividend yield theory.
- 01/01/2022
|
West to Participate in Upcoming Investor Conference
- EXTON, Pa., Dec. 27, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference taking place virtually on January 10, 2022.
- 12/27/2021
|
West Pharmaceutical Services (WST) Outpaces Stock Market Gains: What You Should Know
- West Pharmaceutical Services (WST) closed at $459.84 in the latest trading session, marking a +1.37% move from the prior day.
- 12/24/2021
|
Is West Pharmaceutical (WST) a Solid Growth Stock? 3 Reasons to Think " Yes "
- West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.
- 12/23/2021
|
Dividend Growth Stock Watchlist - December 2021
- There are 24 stocks on my dividend growth watchlist for December 2021. Nine of the stocks on my watchlist are currently undervalued based on dividend yield theory.
- 12/13/2021
|
3 Reasons Why West Pharmaceutical (WST) Is a Great Growth Stock
- West Pharmaceutical (WST) could produce exceptional returns because of its solid growth attributes.
- 12/07/2021
|
Top 15 High Growth Dividend Stocks For December 2021
- I present my top 15 high-growth dividend stocks to consider during the month of December.
- 12/07/2021
|
4 MedTech Dividend Stocks in Focus on Amid Omicron Variant Panic
- Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.
- 12/02/2021
|
Is West Pharmaceutical Services (WST) a Great Growth Stock?
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider West Pharmaceutical Services (WST).
- 11/30/2021
|
3 Promising Stocks From the Buoyant Dental Supplies Industry
- Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 11/23/2021
|
Here's Why You Should Invest in West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum on the back of strength in Proprietary Products business.
- 11/16/2021
|
3 Reasons Why West Pharmaceutical (WST) Is a Great Growth Stock
- West Pharmaceutical (WST) could produce exceptional returns because of its solid growth attributes.
- 11/15/2021
|
West to Participate in Upcoming Investor Conferences
- EXTON, Pa., Nov. 11, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the Jefferies London Healthcare Conference taking place on November 16-18, 2021 in London, UK. Management will participate in a Fireside Chat on Tuesday, November 16, 2021 from 5:40 p.m.
- 11/11/2021
|
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
- West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.12% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could have purchased 40.06 shares of West Pharmaceutical Servs at the time with $1,000.
- 11/09/2021
|
Top 15 Dividend Growth Stocks For November 2021
- I present my top 15 dividend growth stocks to consider during the month of November. Last month's list returned 8.52% in October, outpacing SPY by 1.5%.
- 11/06/2021
|
West Pharmaceutical (WST) Q3 Earnings & Revenues Beat Estimates
- West Pharmaceutical's (WST) third-quarter earnings reflect segmental strong performance.
- 10/28/2021
|
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of 13.19% and 3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2021
|
Is a Surprise Coming for West Pharmaceutical Services (WST) This Earnings Season?
- West Pharmaceutical Services (WST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 10/27/2021
|
West Introduces DeltaCube™ Modeling Platform and NovaGuard® SA Pro Safety System for 0.5 mL Standard Glass Syringes at Interphex
- EXTON, Pa., Oct. 19, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will unveil its DeltaCube™ Modeling Platform as well as the new NovaGuard® SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex, taking place October 19 to 21 in New York, New York. The DeltaCube™ Modeling Platform is an online vial integrity modeling platform designed to help developers make more confident decisions about their container closure systems.
- 10/19/2021
|
West to Host Third-Quarter 2021 Conference Call
- EXTON, Pa., Oct. 14, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2021 financial results before the market opens on Thursday, October 28, 2021, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 10/14/2021
|
5 High-Quality Stocks Outperforming the S&P 500
- In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to date are Alphabet Inc. ( GOOGL , Financial)( GOOG , Financial), Old Dominion Freight Line ( ODFL , Financial), West Pharmaceutical Services Inc. ( WST , Financial), The Descartes Systems Group Inc. ( DSGX , Financial) and LeMaitre Vascular Inc. ( LMAT , Financial) according to the High Quality Low CapEx Screener, a Premium screen nested within GuruFocus' All-in-One Screener.
- 10/05/2021
|
3 High-Potential MedTech Stocks With More Than 50% Growth YTD
- Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.
- 09/29/2021
|
S&P 500 Records a Broad-Based Rally YTD: 5 Top-Ranked Picks
- We have narrowed down our search to five large-cap S&P 500 stocks that have strong growth potential for the rest of 2021. These are AZO, MOS, ULTA, ORLY, and WST.
- 09/27/2021
|
3 Best ESG Stocks for Those Committed to Sustainable Investing
- Investors who prioritize sustainable investing should buy these ESG stocks The post 3 Best ESG Stocks for Those Committed to Sustainable Investing appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America's #1 EV Stock Still Flying Under the Radar
- 09/23/2021
|
3 Dental Stocks Poised to Perform Well in Second-Half 2021
- Let's keep a watch on three lucrative stocks, WST, HSIC and MMSI, in the dental space that investors can add to their watchlist backed by robust long-term prospects.
- 09/16/2021
|
Dividend Growth Stock Watchlist - September 2021
- Dividend Growth Stock Watchlist - September 2021
- 09/14/2021
|
7 Top-Performing S&P 500 Stocks to Watch
- This list of top-performing S&P 500 stocks demonstrates why these companies are doing so well in one of the best bull markets in history. The post 7 Top-Performing S&P 500 Stocks to Watch appeared first on InvestorPlace.
- 09/08/2021
|
What Makes West Pharmaceutical Services (WST) a Strong Momentum Stock: Buy Now?
- Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 09/06/2021
|
West Pharmaceutical (WST) Hits 52-Week High, Can the Run Continue?
- West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 09/06/2021
|
Here is Why Growth Investors Should Buy West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) could produce exceptional returns because of its solid growth attributes.
- 08/25/2021
|
West Elects New Director to the Board
- EXTON, Pa., Aug. 23, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the Company's Board of Directors has elected Molly Joseph as its newest member. With the addition of Ms.
- 08/23/2021
|
Here's Why You Should Invest in West Pharmaceutical (WST) Now
- West Pharmaceutical (WST) continues to gain momentum on the back of strength in Proprietary Products business.
- 08/23/2021
|
Sustainability Trends Boost ESG Investing: 5 Green Picks
- ESG investing will get a boost from sustainability trends, which calls for investing in Microsoft (MSFT), EMCOR Group (EME), West Pharmaceutical (WST), Deere (DE) & Texas Instruments (TXN).
- 08/20/2021
|
Dividend Aristocrats: 5 To Buy And 5 To Avoid
- Dividend Aristocrats: 5 To Buy And 5 To Avoid
- 08/20/2021
|
West Pharmaceutical (WST) Hits 52-Week High: What's Driving It?
- Investors are optimistic about West Pharmaceutical's (WST) robust proprietary products segment and its continued strength in R&D.
- 08/18/2021
|
West Pharmaceutical (WST) Moves to Strong Buy: Rationale Behind the Upgrade
- West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 08/16/2021
|
Is West Pharmaceutical (WST) a Solid Growth Stock? 3 Reasons to Think " Yes "
- West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.
- 08/05/2021
|
Here's Why West Pharmaceutical Services (WST) is a Great Momentum Stock to Buy
- Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/05/2021
|
Earnings Estimates Rising for West Pharmaceutical (WST): Will It Gain?
- West Pharmaceutical (WST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 08/03/2021
|
West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q2 2021 Results - Earnings Call Transcript
- West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q2 2021 Results - Earnings Call Transcript
- 07/29/2021
|
West Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of 41.38% and 8.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2021
|
Recap: West Pharmaceutical Services Q2 Earnings
- Shares of West Pharmaceutical Servs (NYSE:WST) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 96.80% over the past year to $2.46, which beat the estimate of $1.74.
- 07/29/2021
|
West Announces Second-Quarter 2021 Results
- EXTON, Pa., July 29, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2021 and updated full-year 2021 financial guidance. Second-Quarter 2021 Summary (comparisons to prior-year period) Net sales of $723.6 million grew 37.3%; organic sales growth was 30.6%.
- 07/29/2021
|
What's in Store for West Pharmaceutical's (WST) Q2 Earnings?
- West Pharmaceutical's (WST) second-quarter results are likely to reflect strength in the Proprietary Products business.
- 07/26/2021
|
Hells Bells - 2 Strong Sells
- On Wall Street, fortunes are made by "buying right and holding on." However, if you grossly overpay for even the world's highest quality companies, you court disaster.
- 07/22/2021
|
3 Stocks to Tap the Promising Dental Supplies Industry
- Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
- 07/15/2021
|
West to Host Second-Quarter 2021 Conference Call
- EXTON, Pa., July 15, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2021 financial results before the market opens on Thursday, July 29, 2021, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 07/15/2021
|
Upcoming Ex-Dividend Dates: July 13-26, 2021
- This article series presents upcoming ex-dividend dates. We provide a summary table with relevant data and key statistics, including the next payout and pay date.
- 07/11/2021
|
Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD
- Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.
- 07/11/2021
|
Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD
- Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.
- 07/09/2021
|
West Pharmaceutical (WST) Hits 52-Week High: What's Driving It?
- Investors are optimistic about West Pharmaceutical's (WST) solid proprietary products segment.
- 07/06/2021
|
Bet on 4 Low-Beta MedTech Stocks to Ride the Choppy Market
- Stocks like Henry Schein (HSIC), BellRing Brands (BRBR), Harrow Health (HROW) and West Pharmaceuticals Services (WST) are solid low-beta picks with strong fundamentals.
- 07/06/2021
|
3 Best MedTech Growth Stocks to Bet On in 2021 Amid Pandemic
- Grab these three top stocks, EYE, WST and HSIC, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.
- 07/01/2021
|
Dividend Growth Stock Watchlist - June 2021
- There are 21 stocks on my dividend growth watchlist for June 2021. The average 10-year dividend growth rate for these stocks is 15.67%.
- 06/10/2021
|
Is West Pharmaceutical (WST) a Great Growth Stock?
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider West Pharmaceutical (WST).
- 06/08/2021
|
3 Reasons Growth Investors Will Love West Pharmaceutical (WST)
- West Pharmaceutical (WST) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 05/28/2021
|
West Announces Participation in Upcoming Investor Conference
- EXTON, Pa., May 25, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present at the Jefferies Virtual Healthcare Conference at 2:30 PM ET on Tuesday, June 1, 2021. A live broadcast of the event will be available at the Company's website, www.westpharma.com, in the "Investors" section under "Events".
- 05/25/2021
|
3 Reasons Why Growth Investors Shouldn't Overlook West Pharmaceutical (WST)
- West Pharmaceutical (WST) possesses solid growth attributes, which could help it handily outperform the market.
- 05/12/2021
|
West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference
- EXTON, Pa., May 5, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2021 dividend of $0.17 per share. The dividend will be paid on August 4, 2021, to shareholders of record as of July 21, 2021.
- 05/05/2021
|
Dividend Aristocrat Performance: April 2021
- Dividend Aristocrat Performance: April 2021
- 05/04/2021
|
West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q1 2021 Results - Earnings Call Transcript
- West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q1 2021 Results - Earnings Call Transcript
- 04/30/2021
|
West Pharmaceutical: Q1 Earnings Insights
- Shares of West Pharmaceutical Servs (NYSE:WST) fell 0.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 102.97% year over year to $2.05, which beat the estimate of $1.43.
- 04/29/2021
|
West Announces First-Quarter 2021 Results
- EXTON, Pa., April 29, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2021 and updated full-year 2021 financial guidance. First-Quarter 2021 Summary (comparisons to prior-year period) Net sales of $670.7 million grew 36.5%; organic sales growth was 31.1%.
- 04/29/2021
|
Are You Overlooking These Stocks of the Future?
- The stocks of the future may also be good for your investment returns in the present.
- 04/21/2021
|
West to Host First-Quarter 2021 Conference Call
- EXTON, Pa., April 15, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2021 financial results before the market opens on Thursday, April 29, 2021, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
- 04/15/2021
|
Quality Dividend Growth Stock Watchlist For April 2021
- I present 30 Quality Dividend Growth Stocks for consideration in April 2021.
- 04/07/2021
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of West Pharmaceutical Services, Inc. (WST)
- New York, New York--(Newsfile Corp. - March 31, 2021) - Levi & Korsinsky announces it has commenced an investigation of West Pharmaceutical Services, Inc. (NYSE: WST) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/west-pharmaceutical-services-inc-information-request-form\or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.
- 03/31/2021
|
West Announces Participation in Upcoming Investor Conference
- EXTON, Pa., March 17, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 10:00 AM ET on Wednesday, March 24, 2021. A live audio webcast of the presentation and a copy of the presentation will be accessible from the Company's website at www.westpharma.com/en/investors.
- 03/17/2021
|
3 Stocks to Capitalize on Promising Dental Supplies Industry
- 3 Stocks to Capitalize on Promising Dental Supplies Industry
- 03/10/2021
|
Steady Rise in ESG Investing to Boost These 5 Stocks
- ESG investing will continue its northward momentum and this calls for investing in NVIDIA (NVDA), Microsoft (MSFT), EMCOR (EME), West Pharma (WST) and Texas Instruments (TXN)
- 03/04/2021
|
West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2020 Results - Earnings Call Transcript
- West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2020 Results - Earnings Call Transcript
- 02/18/2021
|
West Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat Estimates
- West Pharmaceutical (WST) delivered earnings and revenue surprises of 18.58% and 7.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/18/2021
|
West Pharmaceutical: Q4 Earnings Insights
- Shares of West Pharmaceutical Servs (NYSE:WST) moved higher by 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 63.41% year over year to $1.34, which beat the estimate of $1.12.
- 02/18/2021
|
A Trio of High-Return Businesses With Solid Balance Sheets
- Their financial strength and profitability have received high ratings.
- 01/29/2021
|
West Pharmaceutical Services: Unique Business, Intimidating Valuation
- West is currently prepping and delivering products and services needed for the Covid-19 vaccine. Holds a leadership position as a pick and shovel play to the pharmaceutical market.
- 01/06/2021
|
7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible
- The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.
- 01/05/2021
|
Stocks hold near highs: Axon Breaks Out; AMD, West Pharmaceutical Near Key Levels
- Stocks hold near highs: Axon breaks out; AMD, West Pharmaceutical near key levels. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 12/23/2020
|
3 Recession-Proof Stocks to Buy With $3,000
- If you're preparing for another market crash, don't overlook these rock star stocks.
- 12/22/2020
|
5 MedTech Stocks That Have Outperformed the Industry in 2020
- Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.
- 12/17/2020
|
Grab 3 Dental Stocks More Than Doubling Industry Gains for 2021
- Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.
- 12/16/2020
|
Have $1,000? Here Are 3 Top Healthcare Stocks to Buy in December
- There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond.
- 12/05/2020
|
COVID-19 Vaccine Rollout Challenges Put These Stocks in Focus
- With COVID-19 vaccine on the horizon, cold-chain storage stocks including TT, CARR and TMO; vial makers like GLW and WST; and logistic operators including UPS and FDX are set to hog the limelight.
- 11/20/2020
|
Has West Pharmaceutical Services (WST) Outpaced Other Medical Stocks This Year?
- Is (WST) Outperforming Other Medical Stocks This Year?
- 11/11/2020
|
Is West Pharmaceutical Services (WST) Outperforming Other Medical Stocks This Year?
- Is (WST) Outperforming Other Medical Stocks This Year?
- 10/26/2020
|
Stocks Dive As Trump Ends Stimulus Talks, West Pharmaceutical, BlackLine, Sea Limited Break Out
- Stocks dive as Trump ends stimulus talks; West Pharmaceutical, BlackLine, Sea break out. Investor’s Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 10/06/2020
|
